Skip to main content
Earnings Labs
BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ·Healthcare·Biotechnology

$55.84

+0.99%

Mkt Cap $10.96B

Analyst Ratings

Buy

19

Hold

6

Sell

0

Price Target (82 analysts)

$90.88

Range $59.00 – $124.00

Implied Upside

+62.8%

Consensus $90.88 vs current $55.84